Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | +1.49K | +8.51% | 19K | May 1, 2023 | Direct | F1 | ||
transaction | OGN | Common Stock | Tax liability | -$10.5K | -425 | -2.24% | $24.63 | 18.6K | May 1, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -1.49K | -100% | $0.00* | 0 | May 1, 2023 | Common Stock | 1.49K | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. On May 1, 2022, 50% of the RSUs vested, and on May 1, 2023, the remaining 50% of the RSUs vested. |